Pancreatic Islet Cell Tumors
Also known as: Islet Cell Tumor / Islet cell tumor (morphologic abnormality) / Benign neoplasm of endocrine pancreas / Islet cell neoplasm (morphologic abnormality) / Neoplasm of endocrine pancreas (disorder) / Islet cell adenoma (morphologic abnormality) / Islet cell adenomatosis (disorder) / Adenoma, Islet Cell
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00683 | Midazolam | 1 | Active Not Recruiting | 1 |
| DB00220 | Nelfinavir | 1 | Active Not Recruiting | 1 |
| DB13925 | Dotatate gallium Ga-68 | 1 / 2 | Unknown Status | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB01101 | Capecitabine | 2 | Completed | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB03275 | Cysteinamide | 2 | Completed | 1 |
| DB01590 | Everolimus | 2 | Terminated | 1 |
| DB00544 | Fluorouracil | 2 | Completed | 1 |
| DB00762 | Irinotecan | 2 | Completed | 1 |
| DB00650 | Leucovorin | 2 | Completed | 1 |
| DB01042 | Melphalan | 2 | Completed | 1 |
| DB05575 | Motesanib | 2 | Completed | 1 |
| DB00104 | Octreotide | 2 | Completed | 1 |
| DB00104 | Octreotide | 2 | Terminated | 1 |
| DB06663 | Pasireotide | 2 | Terminated | 1 |
| DB00428 | Streptozocin | 2 | Completed | 1 |
| DB01268 | Sunitinib | 2 | Completed | 1 |
| DB01041 | Thalidomide | 2 | Completed | 1 |
| DB00112 | Bevacizumab | 2 / 3 | Terminated | 1 |
| DB00544 | Fluorouracil | 2 / 3 | Terminated | 1 |
| DB00650 | Leucovorin | 2 / 3 | Terminated | 1 |
| DB00526 | Oxaliplatin | 2 / 3 | Terminated | 1 |
| DB00997 | Doxorubicin | Not Available | Terminated | 1 |